Enzo Biochem, Inc. announced that the Enzo Board of Directors has formed two new committees to support strategy related to targeting and execution of new business opportunities and development and support for new members of the leadership team within the Company. The newly formed Corporate Development Committee is led by newly elected board member Ian Walters, MD & MBA, and independent board member Dov Perlysky, MBA. They will evaluate and provide guidance to the Company on acquisition, divestiture, and partnership opportunities within the life sciences industry. Both directors will work to support Enzo’s internal M&A team in identifying and assessing business development opportunities. The Company’s Board of Directors has ninety days from the election results certification to make a decision with respect to Dr. Rabbani’s offered resignation from his position as Chairman of the Board.